Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články, tisková chyba
PubMed
32943636
PubMed Central
PMC7499156
DOI
10.1038/s41467-020-18719-8
PII: 10.1038/s41467-020-18719-8
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- tisková chyba MeSH
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Caryl and Israel Englander Institute for Precision Medicine New York NY USA
Center of Clinical Investigations in Biotherapies of Cancer 1428 Villejuif France
Department of Cancer Medicine Gustave Roussy Cancer Center Villejuif France
Department of Dermatology Yale School of Medicine New Haven CT USA
Department of Radiation Oncology Weill Cornell Medical College New York NY USA
Department of Women's and Children's Health Karolinska University Hospital Stockholm Sweden
Faculté de Médecine Université de Paris Sud Paris Saclay Le Kremlin Bicêtre Paris France
Gustave Roussy Cancer Center Villejuif France
Institute of Medical Immunology Martin Luther University Halle Wittenberg Halle Germany
Pôle de Biologie Hôpital Européen Georges Pompidou AP HP Paris France
Sandra and Edward Meyer Cancer Center New York NY USA
Sorbonne Université Inserm CNRS Centre d'Immunologie et des Maladies Infectieuses CIMI Paris France
Suzhou Institute for Systems Medicine Chinese Academy of Medical Sciences Suzhou China
Citace poskytuje Crossref.org
